Quel est le site Web ?

Convatec Cicatrisation

Page d'Accueil
France
La Garenne-Colombes
Convatec Cicatrisation

Leaders mondiaux dans le soin des , les Laboratoires ConvaTec développent et commercialisent des technologies innovantes.

Nous accompagnons les professionnels de santé dans la prise en charge des plaies à l’hôpital comme à la ville.

25/08/2025

Better, faster, safer. Aquacel® Ag+ Extra™.¹ 🔍

In a recent randomised controlled trial, it was revealed that Aquacel® Ag+ Extra™ drives a higher probability of closure and fewer dressing-related complications than Cutimed® Sorbact®.¹

The data also demonstrated faster healing and a lower adverse-event burden.¹

Discover the headline findings of the trial below. 📽️

References:

1. Beraldo. S. et al., "Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial," Journal of Wound Care, vol. 34, no. 3, 24 February, 2025, pp. 170 - 178, , accessed 30 July, 2025.

21/08/2025

What is the NICE HTE27 guidance and why does it matter? 🤔

LSA guidance evaluates dressings on three fronts: clinical efficacy, cost-effectiveness and environmental considerations.¹

Aquacel® Ag+ Extra™ combines two powerful technologies: MORE THAN SILVER™ technology that disrupts biofilm and Hydrofiber® Technology which helps manage exudate.²

Swipe below for the headlines from this evaluation. ⤵️

References:

1. National Institute for Health and Care Excellence, “Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessment,” HTE27, 19 June, 2025, , accessed 16 Jul, 2025.

2. Bowler PG, Parsons, D. Combatting wound biofilm and recalcitrance with a novel anti-biofilm Hydrofiber® wound dressing. Wound Medicine 14 (2016) 6–11

20/08/2025

Be Sure in 4 with the Wound Hygiene Pathway.¹ 4️⃣

Biofilm is a major barrier to healing: it's present in nearly 8 out of 10 hard-to-heal wounds² and delays wound healing.³

The Convatec four-step Wound Hygiene Pathway improves healing rates and lowers infection risk.¹

Swipe below to discover the steps. 📲

References:

1. Murphy C, Atkin L, Swanson T, Tachi M, Tan YK, Vega de Ceniga M, Weir D, Wolcott R. International consensus document. Defying hard-to-heal wounds with an early antibiofilm intervention strategy: Wound Hygiene. J Wound Care 2020; 29(Suppl 3b):S1–28

2. Malone. M. et al., “The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data,” Journal of Wound Care, vol. 26, no. 1, 19 January, 2017, pp. 20-25, , accessed 16 July, 2025.

3. Metcalf. D G. et al., “Biofilm delays wound healing: A review of the evidence,” Burns & Trauma, vol. 1, no. 1, 18 June, 2013, pp. 5-12, , accessed 16 July, 2025.

19/08/2025

Five weeks to heal then back to the pool with the Convatec Wound Hygiene Pathway and Aquacel® Extra™. 🏊‍♀️

After her last surgery, Anne expected she would have to wait 8 months for her wound to heal when she had to have another procedure²

That was until nurse Jay combined the Convatec Wound Hygiene Pathway³ with Aquacel® Extra™ Dressing.¹ The wound closed in just five weeks, not eight months.²

‘It healed the wound so much faster… I was back swimming in five or six weeks.²

Here's Jay and Anne to tell their story. 📺

References:
1. Convatec, “Aquacel® Extra™ Dressing,” 2025, , accessed 16 July, 2025.

2. Data on file, “Jay & Anne Case Study,” AP-74454-GBL-ENG-v1, Convatec, 2024.

3. Convatec, “Wound Hygiene,” 2025, , accessed 16 July, 2025.

31/07/2025

Designed with high tensile strength to be removed in one-piece easily²⁵ and eliminating pain at dressing change²⁴, Aquacel® Extra™ can be cut in any direction without compromising its integrity.²⁶
*Machine direction

Aquacel® Extra™ has superior wet tensile strength to other* than other fibre dressings such as Biatain® Fiber, Exufiber® and alginate dressings (Askina® Sorb and Algosteril®).²⁷
*Machine direction

In clinical practice, alginate dressings were difficult to remove due to dressings breaking up or being mistaken for devitalised tissue and being left in the wound.²⁵

References:
24. Barnea Y, Amir A, Lesham D et al. (2004) ‘Clinical comparative study of Aquacel® and paraffin gauze dressing for split-skin donor site treatment’, Ann Plast Surg,132-113
25. Leek K. (2022) Exploring the differences between alginate & gelling fibre dressings for managing exudate and improving clinical outcomes. Wound Care Today Conference poster.
26. Aquacel Extra™ Instruction For Use 1738657V1.
27. AWC-2022-005 ver 3.0 Convatec (2022) Data on file

29/07/2025

In this video, Prof. Dr. med. Joachim Dissemond, Dermatologist, University Hospital Essen, Germany, discusses the results found in our latest randomised clinical trial (RCT) on Aquacel® Ag+ Extra™ vs DACC antimicrobial dressings.

Download the summary or find out more here: https://brnw.ch/21wUuYX

25/07/2025

Aquacel® Extra™’s Hydrofiber™ technology expertly balances a range of wound-healing attributes.

Aquacel® Extra™ transforms into a gel that micro-contours to the wound bed, balancing moisture and leaving no gaps for bacteria to proliferate.²¹ ²² ²³

Find out more here:
https://brnw.ch/21wUq3C

References:
21. Walker M, Parsons D. (2010) ‘Hydrofiber® Technology: its role in exudate management’, 31-8
22. Hoekstra MJ et al. (2002) A histological comparison of acute inflammatory responses with a Hydrofiber or tulle gauze dressing. J Wound Care; 11(3): 113- 17.
23. Bowler P, Jones S, Towers V et al. (2010) ‘Dressing conformability and silver-containing wound dressings’, Wounds, 14–20

22/07/2025

In this video Daniel Metcalf, PhD, Research and Development Director, Convatec, discusses the randomised clinical trial (RCT) on Aquacel® Ag+ Extra™ vs DACC antimicrobial dressings.

Download the summary or find out more here: https://brnw.ch/21wUks1

16/07/2025

Aquacel® Extra™ absorbs up to 30 times its weight and retains its integrity¹² ¹³ ¹⁵ ¹⁹ ²⁰ to minimise risk of excess exudate and leakage even under compression.¹² ¹³ Its high exudate absorption and retention has shown fewer dressing changes in clinical practice.¹⁴ ¹⁷ ¹⁸

Aquacel® Extra™ provides better absorbency and retention* than Exufiber®, Biatain® Fiber and alginate dressings, such as Askina Sorb and Algosteril.¹⁶

*under GSM per square meter calculation

Find out more here:
https://brnw.ch/21wUba7

References:

12. Waring MJ, Parsons D. (2001) ‘Physico-chemical characterisation of carboxymethylated spun cellulose fibres’, Biomaterials, 903-912
13. Walker M, Parsons D. (2010) ‘Hydrofiber® Technology: its role in exudate management’, 31-8.
14. Harding KG, et al, (2001) ‘Cost and dressing evaluation of Hydrofiber® and alginate dressings in the management of community-based patients with chronic ulceration’. Wounds 229-36
15. Carrere, C et al. (2021) ‘Community Setting Survey Evaluating Aquacel® Dressings’, Journal of Wound Care, VOL 30, (NO 9), 763-774
16. AWC-2022-005 ver 3.0 Convatec (2022) Data on file.
17. Moore PJ, Foster L. (2000) ‘Cost benefits of two dressings in the management of surgical wounds’, Br J Nurs, 1128-1132.
18. Tomasi J, Claude Y, Lucas A. (2020) ‘The partner study: first results of two synergistics dressings in the management of acute and chronic wounds in community setting’. WUWHS.
19. Tickle J, (2012) ‘Effective management of exudate with Aquacel® ExtraTM, BrJCommNurs, 38-46. 21.
20. Williams C. (1999) An investigation of the benefits of Aquacel® Hydrofibre wound dressing. Br J Nurs, 8(10):676–677, 680. https://brnw.ch/21wUba8 bjon.1999.8.10.6607

10/07/2025

Aquacel® Extra™’s Hydrofiber™ technology expertly balances a range of wound-healing attributes.

Aquacel® Extra™’s vertical wicking / absorption transfers fluid away from the wound bed, protecting periwound skin from maceration. ⁷ ⁹

Aquacel® Extra™ can be used in combination with ConvaMax™ and Aquacel® Foam to have a synergistic effect of Hydrofiber™ Technology layers.⁸ ¹⁰ ¹¹

Find out more here:
https://brnw.ch/21wU2xK

References:
7. Waring MJ, Parsons D. (2001) ‘Physico-chemical characterisation of carboxymethylated spun cellulose fibres’, Biomaterials, 903-912
8. Aquacel® Ribbon Instructions for Use 1738658V1.
9. An open randomized comparative study to evaluate the performance of two absorbent dressings in venous leg ulcers (VLU). Convatec (2013)

Data on file.
10. AQUACEL® Foam Instructions for Use 1714576V1.
11. WHRI3891 MA243 Convatec (2014) Data on file

09/07/2025

New NICE guidance on topical antimicrobial dressings. What does this mean for clinical practice?

The latest evaluation from NICE - National Institute for Health and Care Excellence provides important clarity on the use of topical antimicrobial dressings such as Convatec’s Aquacel® Ag+ Extra™ for locally infected leg ulcers, a topic of growing clinical relevance¹.

This guidance forms part of NICE’s Later-Stage Assessment (LSA) framework, which evaluates categories of technologies already in widespread NHS use in the UK. It specifically assesses whether differences in innovation, clinical effectiveness and patient benefits justify the price variation across products in the same category.

This insight is key for NHS commissioners, procurement teams, clinicians and patients alike, helping ensure decisions are driven by both clinical value and cost-effectiveness.

At Convatec and within advanced wound care, we strongly believe clinical decision-making should be rooted in high-quality evidence and are committed to deliver the benefits of innovation that give healthcare professionals the tools they need to help improve patient outcomes.

The LSA reinforces the importance of targeted, judicious antimicrobial use, supporting best practice and contributing to antimicrobial stewardship.

We’re proud to collaborate with the NHS and welcome the latest NICE guidance on topical antimicrobial dressings that raises the standard of care across the system.

To help you digest and apply this guidance, we’ve developed information on our clinical effectiveness for Aquacel® Ag+ Extra™.

09/07/2025

In this video, Stefanie Beraldo, Specialist for General Surgery, DRK Hospital Mölln-Ratzeburg, Germany, the author of latest RCT study, discusses results on Aquacel® Ag+ Extra™ vs DACC antimicrobial dressings.

Download the summary or find out more here: https://brnw.ch/21wU0oI

11/06/2024

[CONGRES]

📅 Retrouvez les Laboratoires Convatec aux Journées Aquitaine Cicatrisation 2024 !

Notre équipe sera présente pour vous accueillir sur notre stand et discuter des dernières actualités.

Nous vous attendons nombreux !

04/06/2024

📅 [CONGRES]

Convatec sera présent le 14 juin à Nice à la 6ème Rencontre Azuréenne de Cicatrisation*!

Venez nous rencontrer et participer à notre atelier « Hygiène des plaies : Et si on passait à la pratique », deux sessions vous sont proposées :

- 10h30 à 11h10
ou
- 11h20 à 12h

📌Plus d’informations sur : https://brnw.ch/21wKqCv

*réservé aux professionnels de santé

24/05/2024

Les escarres constituent un problème majeur dans le monde entier. Saurez-vous deviner quelle est leur prévalence dans les établissements de soins aigus ?

A) 6 à 10%
B) 6 à 13.5%
C) 6 à 16%
D) 6 à 18.5%

14/05/2024

Lorsqu’une plaie se forme, l'inflammation causée par celle-ci va provoquer la dilatation des vaisseaux sanguins. Un écoulement de liquide va alors se créer par capillarité vers le tissu endommagé afin d’initier la cicatrisation de la plaie. Cet excès de liquide constitue la base de l’exsudat.

La production d'exsudat est un processus normal faisant partie de la cicatrisation : des cellules, des protéines et des nutriments sont transportés dans l'exsudat permettant à la plaie de cicatriser. Au cours du temps, la production d'exsudat va diminuer jusqu’à cicatrisation complète de la plaie.

12/05/2024

En cette Journée Internationale des Infirmières, nous souhaitions mettre en avant le travail de toute la profession infirmière qui chaque jour, œuvre à améliorer la qualité de vie de ses patients porteurs de plaies.

30/04/2024

Convatec s'engage dans la prévention et la cicatrisation des plaies.

Découvrez en vidéo comment nos équipes s’engagent à vos côtés pour prendre soin des patients et améliorer leur qualité de vie.

24/04/2024

Une r***e de la littérature polonaise a montré que la Thérapie par Pression Négative (TPN) était plus efficace dans le traitement des ulcères du pied diabétique que la thérapie traditionnelle.*

Les résultats ont également montré que, bien que les coûts associés à la TPN soient plus élevés, la méthode était plus économique dans l'ensemble.*

Selon vous, quel critère suivant ne constitue pas un avantage de la TPN ?

A) La réduction du temps de cicatrisation
B) La formation plus rapide du tissu de granulation
C) La diminution de la fréquence de changement du pansement
D) L’aspect pratique pour le patient
E) La réduction du risque d’amputation

Adresse

La Garenne-Colombes

Site Web

https://www.convatec.fr/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Convatec Cicatrisation publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.